Rezolute, Inc. Common Stock (NV)

RZLTNASDAQ • USD
3.51 USD
↘ 0.15 (4.10%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Rezolute, Inc. Common Stock (NV) (RZLT) is currently trading at $3.51. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place RZLT at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.65
High?$3.84
Low?$3.37
Prev. Close?$3.66
Volume?3.0M
Avg. Volume?1.7M
VWAP?$3.53
Rel. Volume?1.84x
Bid / Ask
Bid?$3.52 × 700
Ask?$3.53 × 900
Spread?$0.01
Midpoint?$3.53
Valuation & Ratios
Market Cap?354.0M
Shares Out?96.7M
Float?85.0M
Float %?87.9%
P/E Ratio?N/A
P/B Ratio?4.12
EPS?-$0.81
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Employees
58
Market Cap
353.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2011-12-23
Address
275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY, CA 94065
Phone: 650-206-4507
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
39
Piotroski F-Score?0/9Weak
Altman Z-Score?12.04Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.76%Squeeze Risk
Short Interest?18.5M
Days to Cover?14.9
Free Float85.0M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.92Strong
Quick Ratio?9.92Strong
Cash Ratio?0.86Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
43
4.12FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-90.7%WEAK▾
ROA?
S&P
3
-81.2%WEAK▾
Cash Flow & Enterprise
FCF?$-65988000
Enterprise Value?$345.9M
Fundamentals ratios updated end of day